Concepedia
Statistics
Publications
2
Citations
35
H-Index
Active since
2024
Affiliations
Université Paris-Saclay(Current)
Institut Gustave Roussy
Samsung Medical Center
Instituto de Investigación Marqués de Valdecilla
Y. Loriot is an author at Université Paris-Saclay.
Publications per year
2024–2025
Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial
Thomas Powles, Michiel S. van der Heijden, Y. Loriot et al. · Annals of Oncology · 2025 · 23 citations · Full text
LBA9 TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety analysis
P. Grivas, T.B. Powles, Christof Vulsteke et al. · Annals of Oncology · 2024 · 12 citations · Full text
1–2 of 2